Navigation Links
Insmed Appoints Will Lewis as President and Chief Executive Officer
Date:9/11/2012

MONMOUTH JUNCTION, N.J., Sept. 11, 2012 /PRNewswire/ -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering from serious orphan lung diseases, today announced the appointment of Will Lewis as President and Chief Executive Officer, effective immediately. Mr. Lewis has also been appointed to the Company's Board of Directors. He succeeds Tim Whitten, who has resigned as President and Chief Executive Officer and as a member of the Company's Board of Directors. In addition, Donald J. Hayden, Jr., who was appointed Executive Chairman in May 2012, will return to his role as Chairman, effective immediately.

Mr. Lewis has more than 20 years of executive experience and a track record of success in the pharmaceutical and finance industries both in the U.S. and internationally. He is the former Co-Founder, President and Chief Financial Officer of Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR).  During his tenure at Aegerion, Mr. Lewis played a pivotal role in re-orienting the company's strategy to focus on orphan disease indications enabling Aegerion to go public in one of the best performing IPOs of 2010. Prior to Aegerion, Mr. Lewis spent more than 10 years working in the U.S. and Europe in investment banking for JP Morgan, Robertson Stephens and Wells Fargo. During his time in banking, he was involved in a broad range of domestic and international capital raising and advisory work valued at more than $20 billion. Mr. Lewis began his career as an Operations Officer with the Central Intelligence Agency. He earned a J.D. and M.B.A. from Case Western Reserve University and a B.A. with Honors from Oberlin College.

"Will has a record of success in the strategic, operational and financial leadership of rapidly growing organizations and has demonstrated the ability to significantly increase
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Insmed to Host 2012 First Quarter Earnings Conference Call
2. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
3. Insmed Announces First Quarter 2012 Financial Results
4. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
5. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
6. Insmed to Host 2012 Second Quarter Earnings Conference Call
7. Insmed Announces Planned Departure Of Chief Financial Officer
8. Pharmaceutical Industry Veteran Al Altomari Elected To Insmeds Board Of Directors
9. Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
10. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
11. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DALLAS , July 2, 2015 ... Type (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), ... Trends and Forecast to 2020", Silage Inoculants & Enzymes ... at a CAGR of 4.0% from 2015 to 2020. ... F igures spread through 194 P ...
(Date:7/2/2015)... , 2. Juli 2015 BGI ... DNA-Screening in Hongkong vom American College of ... Hongkong ist das erste klinische Next-Generation-Sequencing Labor, ... ein CAP-Zertifkat erhält und somit die höchsten ... den bestehenden US FDA - 21 CFR ...
(Date:7/2/2015)... , July 2, 2015  AbbVie (NYSE: ABBV ... Friday, July 24, 2015, before the market opens. ... earnings conference call at 8 a.m. Central time (9 ... Relations website at www.abbvieinvestor.com . An archived edition ... Central time. About AbbVie AbbVie ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... The ZAC ... the 2015 swim season with important lessons on how to stay water safe with ... Who Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... announced today that it has reached an agreement to acquire eRubbermaid.com, an ... largest distributor of Rubbermaid Commercial Products on the web today. ...
(Date:7/2/2015)... PA (PRWEB) , ... July 02, 2015 , ... ... Vaccine Research (CVR) recently received nearly $4 million through five federal grants ... develop vaccines and therapies against the deadly diseases. , The research will ...
(Date:7/2/2015)... ... 02, 2015 , ... B. E. Smith, the only full-service ... a national chief operating officer recruitment for Nicklaus Children’s Hospital in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Nutraceutical company, is announcing with their launch an intention to partner with companies ... health solutions on the planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3
... -- A NewYork-Presbyterian Hospital/Weill Cornell Medical Center review of almost ... therapy reported in a widely publicized study was lost in ... The researchers report in the May ... Medical Association, that medical therapy given to patients who ...
... (HealthDay News) -- Shortages of anesthetics are rampant across the ... The findings revealed that more than 90 percent of ... States) are experiencing a shortage of at least one drug. ... encountered a similar problem, the poll by the American Society ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... -- best known as Tylenol -- regularly for some ... for developing certain blood cancers, University of Washington researchers ... the association between over-the-counter painkillers or nonsteroidal anti-inflammatory drugs ...
... HealthDay Reporter , TUESDAY, May 10 (HealthDay News) -- ... scan the inside of the colon may one day be ... from Japan,s Osaka Medical College have developed a "self-propelled capsule ... through the colon via remote control and a magnetic field, ...
... from the UCLA Center for Health Policy Research, the majority ... health insurance coverage initiatives in California in 2014 are also ... health services: men, singles and those of working age. ... the federal Patient Protection and Affordable Care Act (ACA), up ...
... adhere to medications for their chronic health problems than ... risk of poor health, according to a new RAND ... a wide array of chronic illnesses such as diabetes ... being non-adherent with their medications compared to patients who ...
Cached Medicine News:Health News:Lessons from major heart trial need implementation 2Health News:Lessons from major heart trial need implementation 3Health News:Lessons from major heart trial need implementation 4Health News:Shortage of Anesthetics Reported 2Health News:Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests 2Health News:Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests 3Health News:A Capsule Camera Instead of a Colonoscopy? 2Health News:A Capsule Camera Instead of a Colonoscopy? 3Health News:2 new studies describe likely beneficiaries of health care reform in California 2Health News:2 new studies describe likely beneficiaries of health care reform in California 3Health News:Depression associated with poor medication adherence in patients with chronic illnesses 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: